Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results
EndocrinologiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- Pituitary
- Publicado em
- 25 jun 2021
- Citações
- 0
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results
Artak Labadzhyan, L B Nachtigall, Maria Fleseriu, M B Gordon, M Molitch, L Kennedy, Susan L Samson, Y Greenman, Nienke R Biermasz, M Bolanowski et al.
Descritores MeSH
- Acromegaly
- Human Growth Hormone
- Humans
- Somatostatin
- Octreotide
- Insulin-Like Growth Factor I
- Capsules
Veja também
Estudos relacionados
- Medical treatment in acromegaly: a network meta-analysis
- Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral Paltusotine
- Maintenance of response to oral octreotide compared with injectable somatostatin receptor ligands in patients with acromegaly: a phase 3, multicentre, randomised controlled trial
- Efficacy and safety of pharmacologic therapies in acromegaly: a systematic literature review and network meta-analysis